Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

@article{Mehta2007UtilizationOD,
  title={Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).},
  author={Sameer K Mehta and Andrew D. Frutkin and Sarah Milford-Beland and Lloyd W Klein and Richard E. Shaw and William Weintraub and Ronald J. Krone and H. Vernon Anderson and Michael A. Kutcher and Steven P. Marso},
  journal={The American journal of cardiology},
  year={2007},
  volume={100 7},
  pages={1114-8}
}
In clinical trials, the use of a distal embolic protection device (EPD) during saphenous vein graft (SVG) percutaneous intervention (PCI) decreases the incidence of major adverse events. However, the frequency of EPD use during SVG PCI in clinical practice is unknown. We evaluated 19,546 SVG PCI procedures in the American College of Cardiology-National Cardiovascular Data Registry from January 1, 2004, through March 30, 2006. EPD use was the primary outcome. Univariate and multivariable… CONTINUE READING